Почетна › Dijabetes tipa 2 › Тексас

Kliničke studije za Dijabetes tipa 2 u državi Тексас

59 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Тексас.

Gradovi u državi Тексас

Zvanični tekst studije (na engleskom)

Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

Texas Diabetes and Endocrinology, Austin
Diabetes and Glandular Disease Clinic, San Antonio

Тражи се учесник

Узраст од 2 до 80 · Оба пола · Ажурирано 13. 11. 2026. · NCT07864168

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Texas Diabetes and Endocrinology - Central Austin, Austin
South Texas Research Institute - Brownsville, Brownsville
Privia Medical Group Gulf Coast, PLLC, Conroe
и још 10

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Pinnacle Clinical Research - Austin, Austin
South Texas Research Institute - Brownsville, Brownsville
Headlands Research - Brownsville, Brownsville
и још 25

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473

A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants

Research Site, San Antonio

Тражи се учесникФаза 1Здраве особе су добродошле

Узраст од 18 до 75 · Оба пола · Ажурирано 12. 11. 2026. · NCT07024823

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston

Тражи се учесникЗдраве особе су добродошлеНаводи исплату за учеснике

Узраст од 14 до 16 · Оба пола · Ажурирано 9. 11. 2026. · NCT06943001

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Houston

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Headlands Research Brownsville, Brownsville
Velocity Clinical Research, Dallas
South Texas Research Institute - Edinburg, Edinburg
и још 5

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

Gadolin Research, Beaumont
Driscoll Children's Hospital, Corpus Christi
Proactive Clinical Research LLC, Edinburg
и још 2

Тражи се учесникФаза 3

Узраст од 10 до 17 · Оба пола · Ажурирано 5. 11. 2026. · NCT07668336

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

PlanIt Research, LLC (Monitoring Room), Houston
PlanIt Research, LLC, Houston
VIP Trials, San Antonio

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

IMA Clinical Research Austin, Austin
Diabetes and Thyroid Center of Ft. Worth, Fort Worth
Juno Research, Houston
и још 5

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07881458

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

IMA Clinical Research Austin, Austin
Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
Velocity Clinical Research, Dallas, Dallas
и још 5

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Juno Research, Houston
Southern Endocrinology Associates, Mesquite
Texas Diabetes & Endocrinology, P.A., Round Rock
и још 2

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Horizon Clinical Research Group, Cypress
Cardiovascular Specialists of Willowbrook, Houston
Texas Cardiology Associates of Houston, Kingwood
и још 2

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Research Site, Dallas
Research Site, McKinney
Research Site, Paris
и још 1

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07662109

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, DeSoto
Research Site, El Paso
Research Site, Houston
и још 5

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Arlington Nephrology, PLLC., Arlington
M3 Wake Research Dallas - Internal Medicine, Dallas
Revival Research Institute, LLC, Dallas
и још 10

Тражи се учесникФаза 2

Узраст од 18 до 80 · Оба пола · Ажурирано 27. 10. 2026. · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Research Site, Dallas
Research Site, Houston
Research Site, Houston
и још 6

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Elligo Health Research, Inc., Austin
Zenos Clinical Research, Dallas
Synergy Group Medical, Houston
и још 3

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 20. 10. 2026. · NCT07502508

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

DM Clinical Research, Tomball

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 19. 10. 2026. · NCT07527650

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Amir Ali Hassan, MD, PA, Houston
Consano Clinical Research, LLC, Shavano Park

Тражи се учесникФаза 3

Узраст од 10 до 18 · Оба пола · Ажурирано 19. 10. 2026. · NCT07282613

The RESET System Pivotal Clinical Trial (Protocol Revision K)

Elevate Clinical Research, Atascocita, Atascocita
M3 Wake Research, Dallas
Epic Medical Research, DeSoto
и још 4

Тражи се учесник

Узраст од 22 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT04101669

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

IMA Clinical Research, Austin
Private Practice - Dr. Laila A. Hassan, Houston
Radiance Clinical Research, Lampasas
и још 3

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT07668388

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Velocity Clinical Research, Austin, Austin
Velocity Clinical Research - Dallas, Dallas
Juno Research, LLC, Houston
и још 8

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07296484

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

University Health - Texas Diabetic Institute, San Antonio
University of Texas Health Science Center at San Antonio, San Antonio

Тражи се учесникФаза 4

Узраст од 18 до 70 · Оба пола · Ажурирано 5. 10. 2026. · NCT06706284

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Elligo Clinical Research Center, Austin
Johnson County Clinical Trials Juno Bellaire, Bellaire
Osvaldo A Brusco MD PA, Corpus Christi
и још 1

Тражи се учесникФаза 3

Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684144

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Baylor Scott & White, Temple

Тражи се учесник

Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06906627

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

Houston Methodist, Houston
Baylor Scott & White, Temple

Тражи се учесник

Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06906640

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Amarillo Med Spec LLP, Amarillo
Texas Diabetes & Endocrinology, Austin
North Texas Endocrine Center, Dallas
и још 6

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07817251

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

University of Texas Southwestern Medical Center, Dallas
Parkland Health & Hospital System (PHHS), Dallas
Baylor Scott and White - Health System, Dallas

Тражи се учесник

Сви узрасти · Оба пола · Ажурирано 29. 9. 2026. · NCT06593327

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Hendrick Health, Abilene
Gadolin Research, Beaumont
CardioVoyage, LLC, Greenville
и још 10

Тражи се учесникЗдраве особе су добродошле

Узраст 55 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06112418

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

The University of Texas Health Science Center at San Antonio, San Antonio

Тражи се учесникЗдраве особе су добродошле

Узраст од 18 до 65 · Оба пола · Ажурирано 22. 9. 2026. · NCT02969798

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Austin
AURORA-2 Clinical Site, Brownsville
AURORA-2 Clinical Site, DeSoto
и још 10

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

University of Texas Southwestern Medical Center, Dallas
JCCT- Juno NW Houston, Houston
Consano Clinical Research, LLC, Shavano Park

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 11. 9. 2026. · NCT07415954

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Research Site, San Antonio

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

PharmaTex Research, Amarillo
Pinnacle Clinical Research, Austin
Javara Inc. / Privia Medical Group Gulf Coast PLLC, Conroe
и још 20

Тражи се учесникФаза 3

Узраст 45 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Research Site, Irving

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 31. 8. 2026. · NCT07662044

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

Texas Diabetes & Endocrinology, Austin

Тражи се учесник

Узраст од 18 до 80 · Оба пола · Ажурирано 28. 8. 2026. · NCT07599982

Quantifying Hepatic Mitochondrial Fluxes in Humans

Texas Diabetes Institute - University Health System, San Antonio
University of Texas Health Science Center at San Antonio, San Antonio

Тражи се учесникФаза 4

Узраст од 18 до 80 · Оба пола · Ажурирано 17. 8. 2026. · NCT05305287

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Research Institute of Dallas, Dallas
Texas Childrens Hospital, Houston
UT Health Houston, Houston

Тражи се учесникФаза 3

Узраст од 10 до 17 · Оба пола · Ажурирано 7. 8. 2026. · NCT06739122

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Research Site, Houston
Research Site, Round Rock
Research Site, San Antonio

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 8. 2026. · NCT07664553

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.